Ameriprise’s Loxo Oncology, Inc LOXO Stock Holding History

Ameriprise’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-304,086	Closed	-$42.6M	–	3845
2018 Q4	$42.6M	Buy	304,086 +80,439	+36%	+$12.2M	0.02%	679
2018 Q3	$38.2M	Buy	223,647 +4,526	+2%	+$761K	0.01%	887
2018 Q2	$38M	Sell	219,121 -123,959	-36%	-$18.6M	0.02%	794
2018 Q1	$39.6M	Buy	343,080 +269,320	+365%	+$28.6M	0.02%	766
2017 Q4	$6.21M	Sell	73,760 -53,506	-42%	-$4.46M	﹤0.01%	1977
2017 Q3	$11.7M	Sell	127,266 -8,510	-6%	-$661K	0.01%	1450
2017 Q2	$10.9M	Buy	135,776 +103,142	+316%	+$5.72M	0.01%	1486
2017 Q1	$1.37M	Sell	32,634 -2,306	-7%	-$95K	﹤0.01%	2738
2016 Q4	$1.12M	Buy	+34,940	New	+$896K	﹤0.01%	2916
2016 Q3	–	Sell	-59,357	Closed	-$1.38M	–	3868
2016 Q2	$1.38M	Sell	59,357 -4,359	-7%	-$109K	﹤0.01%	2730
2016 Q1	$1.74M	Buy	+63,716	New	+$1.33M	﹤0.01%	2590

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Ameriprise's LOXO Position: Q1 2019 in Review

Ameriprise sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 304,086 shares — an estimated $42.6M sold.

Ameriprise first reported a position in LOXO in Q1 2016 and held it in 11 quarters. The position peaked at $42.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Ameriprise reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Ameriprise sold 304,086 Loxo Oncology, Inc shares in Q1 2019, an estimated $42.6M.
Ameriprise first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 11 quarters.
Ameriprise's Loxo Oncology, Inc position peaked at $42.6M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Ameriprise's 13F filing for Q1 2019, filed 15 May 2019.